
Biopharmaceutical Expense Consolidation
Explore
28.10.2024
The Challenge: Merging Two Global Entities
A leading biopharmaceutical company with $1.8 billion in revenue and 10,000 employees across 50+ countries needed to consolidate its expense systems following a significant acquisition. As an existing SAP Concur customer, the company aimed to harmonise policies and implement best practices for expense management.
Our Approach
We led the consolidation and re-platforming, focusing on standardising SAP Concur Expense features and integrating cash advances, ensuring seamless policy harmonisation across both entities.
Results
- Successfully consolidated systems.
- Standardised expense processes globally.
- Delivered on time and within budget.
The consolidation resulted in streamlined expense processes and policy standardisation, helping the company achieve greater operational efficiency within the expected timeline and budget.

Related Studies

